BioMarin Pharmaceuticals BMRN Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $105.53M— | —— | -$30.74M-113% | $240.53M+29.5% | $185.69M+48.6% | ||
| $16.41M-19.7% | $20.44M+10.6% | $18.49M-0.4% | $18.56M-15.9% | $22.07M-6.5% | ||
| $43.46M-7.4% | $46.91M-4.8% | $49.27M+3.6% | $47.53M+26.1% | $37.7M-27.4% | ||
| $220.65M+121% | $99.64M-73.0% | $368.69M+99.0% | $185.27M+6.2% | $174.39M-6.1% | ||
| $20.92M-48.6% | $40.72M+43.2% | $28.45M+66.3% | $17.1M+2.0% | $16.77M-14.1% | ||
| $725.53M+1,809% | -$42.45M+87.2% | -$330.96M-2,528% | -$12.59M+55.4% | -$28.24M-137% | ||
| $850M— | —— | —— | —— | $0— | ||
| $813.17M— | $0+100% | -$2.17M+52.9% | -$4.6M+88.1% | -$38.78M— | ||
| $1.76B+2,760% | $61.57M+69.7% | $36.29M-78.0% | $165.01M+55.7% | $105.96M-60.4% | ||
| $199.73M+239% | $58.92M-82.7% | $340.24M+102% | $168.17M+6.7% | $157.63M-5.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does BioMarin Pharmaceuticals generate?
- BioMarin Pharmaceuticals (BMRN) generated $874.3M in operating cash flow over the trailing twelve months.
- What is BioMarin Pharmaceuticals's free cash flow?
- After $107.2M of capital expenditures, BioMarin Pharmaceuticals's free cash flow was $767.1M over the trailing twelve months, up 22.9% year over year.
- Where does BioMarin Pharmaceuticals's cash flow data come from?
- Every line is extracted from BioMarin Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
